...
机译:挑战的开发和报销个性化medicine-payer和制造商观点和对健康的影响经济和效果研究:一个报告ISPOR个性化医疗的特殊利益集团
University of Manchester, Manchester, United Kingdom;
UMIT, University for Health Sciences, Medical Informatics and Technology, Hall i. Tirol, Austria;
Office of Health Economics, London, United KingdomUniversity of Washington, Seattle, WA, United StatesPremera Blue Cross, Mountlake Terrace, WA, United StatesDaiichi Sankyo, Princeton, NJ, United StatesUniversity of Arizona, Tucson, AZ, United StatesBangor University, Bangor, United KingdomQuintiles Global Consulting, Durham, NC, United States, RTI Health Solutions, RTP, NC, UnitedGhent University, Ghent, BelgiumOregon Health Sciences University, Portland, OR, United StatesHealth Outcomes Strategies, Basel, SwitzerlandCedar Associates, Menlo Park, CA, United States, Stanford University, Palo Alto, CA, United States;
Precision Medicine; health economics; Biomedical Technology AssessmentInterest groupsOutcomes ResearchBest Practices;
机译:Central South University Reports Findings in Personalized Medicine (Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine)
机译:A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models
机译:Heidelberg University Hospital Reports Findings in Personalized Medicine (Surgomics: personalized prediction of morbidity, mortality and long-term outcome in surgery using machine learning on multimodal data)